1,2-dibromopyracylene: a new aromatic system.

B. Trost,D. R. Brittelli

DOI: https://doi.org/10.1016/S0040-4039(00)90498-2

IF: 2.032

Tetrahedron Letters

Abstract:

What problem does this paper attempt to address?

Efficacy and molecular mechanisms of hesperidin in mitigating Alzheimer's disease: A systematic review

Xu Han,Yuting Zhang,Lijuan Zhang,Yanyan Zhuang,Yu Wang

DOI: https://doi.org/10.1016/j.ejmech.2024.117144

IF: 7.088

2024-12-07

European Journal of Medicinal Chemistry

Abstract:Hesperidin, a flavonoid glycoside, is a natural phenolic compound that has broad biological effects. Increasing evidence suggests that hesperidin inhibits the occurrence and development of neurodegenerative diseases, including Alzheimer's disease (AD). This article reviews the neuropharmacological mechanisms of hesperidin in the prevention and treatment of AD through in vitro and in vivo studies. A systematic review of preclinical studies was conducted using PubMed, Web of Science, Scopus, and Google Scholar (up to July 1, 2024). The neuroprotective potential of hesperidin was mediated through mechanisms such as inhibition of β-amyloid (Aβ) aggregation, enhancement of endogenous antioxidant defense functions, reduction of neuroinflammation and apoptosis, improvement of mitochondrial dysfunction, regulation of autophagy, and promotion of neurogenesis. Despite various preclinical studies on the role of hesperidin in AD, its exact effects on humans remain unclear. Few clinical trials have indicated that dietary supplements rich in hesperidin can improve cerebral blood flow, cognition, and memory performance. The neuroprotective effect of hesperidin may be exerted via regulating different molecular pathways, including the RAGE/NF-κB, Akt/Nrf2, and AMPK/BDNF/CREB pathways. However, further clinical trials are needed to confirm the neuroprotective effects of this natural flavonoid compound and to assess its safety.

chemistry, medicinal
Iron stores in pregnancy.

E. George,N. Adeeb,Jahangir Ahmad

1980-12-01

Abstract:SUMMARY Serum ferritin concentration has been measur ed in pregnant women at their first antenatal visit. Results were analysed according to trimes ters. With progression of the pregnancy there is a fall in serum ferritin concentrations.
Potential Benefits of Nobiletin, A Citrus Flavonoid, against Alzheimer’s Disease and Parkinson’s Disease

Akira Nakajima,Yasushi Ohizumi

DOI: https://doi.org/10.3390/ijms20143380

IF: 5.6

2019-07-10

International Journal of Molecular Sciences

Abstract:Alzheimer’s disease (AD), which is characterized by the presence of amyloid-β (Aβ) plaques and neurofibrillary tangles, accompanied by neurodegeneration, is the most common form of age-related neurodegenerative disease. Parkinson’s disease (PD) is the second most common neurodegenerative disease after AD, and is characterized by early prominent loss of dopaminergic neurons in the substantia nigra pars compacta. As currently available treatments are not able to significantly alter the progression of these diseases, successful therapeutic and preventive interventions are strongly needed. In the course of our survey of substances from natural resources having anti-dementia and neuroprotective activity, we found nobiletin, a polymethoxylated flavone from the peel of Citrus depressa. Nobiletin improved cognitive deficits and the pathological features of AD, such as Aβ pathology, hyperphosphorylation of tau, and oxidative stress, in animal models of AD. In addition, nobiletin improved motor and cognitive deficits in PD animal models. These observations suggest that nobiletin has the potential to become a novel drug for the treatment and prevention of neurodegenerative diseases such as AD and PD.

biochemistry & molecular biology,chemistry, multidisciplinary
Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease

Nady Braidy,Sahar Behzad,Solomon Habtemariam,Touqeer Ahmed,Maria Daglia,Seyed Mohammad Nabavi,Eduardo Sobarzo-Sanchez,Seyed Fazel Nabavi

DOI: https://doi.org/10.2174/1871527316666170328113309

2017-07-05

Abstract:Neurodegenerative diseases, namely Alzheimer's disease and Parkinson's disease represent a deleterious impact worldwide. Despite extensive preclinical and clinical research in neurodegenerative disorders, therapeutic strategies aimed at the prevention and chronic treatment of neurodegenerative conditions have not been successfully translated to the clinic. Therefore, the identification of novel pharmacological intervention derived from natural products is warranted. Nobiletin and tangeretin are important citrus flavonoids derived from the peel and other parts of Citrus L. genus, and have been shown to exhibit neuroprotective effects in several in vitro and in vivo studies. Apart from there antioxidant and anti-inflammatory effects, nobiletin and tangeretin have been shown to attenuate cholinergic deficits, reduce the abnormal accumulation of neurotoxic amyloid-beta peptides, reverse N-methyl- D-aspartate (NMDA) receptor hypofunction, ameliorate ischemic injury, inhibit hyperphosphorylation of tau protein, enhance neprilysin levels, modulate several signaling cascades, and protect against 1-methyl-4-phenylpyridinium (MPP(+)) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity. Taken together, these naturally occurring phytochemicals may represent beneficial drug candidates for the treatment and prevention of Alzheimer's and Parkinson's disease.

English Else
Therapeutic Effects of Plant Anthocyanin against Alzheimer's Disease and Modulate Gut Health, Short-Chain Fatty Acids

Al Borhan Bayazid,Beong Ou Lim

DOI: https://doi.org/10.3390/nu16111554

IF: 5.9

2024-05-22

Nutrients

Abstract:Alzheimer's disease (AD) is the most common form of dementia and neurogenerative disease (NDD), and it is also one of the leading causes of death worldwide. The number of AD patients is over 55 million according to 2020 Alzheimer's Disease International (ADI), and the number is increasing drastically without any effective cure. In this review, we discuss and analyze the potential role of anthocyanins (ACNs) against AD while understanding the molecular mechanisms. ACNs have been reported as having neuroprotective effects by mitigating cognitive impairments, apoptotic markers, neuroinflammation, aberrant amyloidogenesis, and tauopathy. Taken together, ACNs could be an important therapeutic agent for combating or delaying the onset of AD.

nutrition & dietetics
Neurocognitive effects of proanthocyanidin in Alzheimer's disease: a systematic review of preclinical evidence

A. Reshma,A. Subramanian,V. Kumarasamy,T. Tamilanban,M. Sekar,S.H. Gan,V. Subramaniyan,L.S. Wong,N.N.I.M. Rani,Y.S. Wu

DOI: https://doi.org/10.1590/1414-431x2024e13587

2024-11-06

Brazilian Journal of Medical and Biological Research

Abstract:Reshma, A. ; Subramanian, A. ; Kumarasamy, V. ; Tamilanban, T. ; Sekar, M. ; Gan, S.h. ; Subramaniyan, V. ; Wong, L.s. ; Rani, N.n.i.m. ; Wu, Y.s. ; Cognitive disorders and dementia largely influence individual independence and orientation. Based on the Alzheimer's Disease International (ADI) estimation, approximately 75% of individuals with dementia are undiagnosed. In fact, in some low- and middle-income countries, the percentage is as high as 90%. In this systematic review, which is based on PRISMA guidelines, we aim to identify the mechanism of action of proanthocyanidin. Finding a natural product alternative as a potential nootropic can help increase the number of armamentariums against dementia and other cognitive impairments. In this preclinical research, we determined the effect of proanthocyanidins on Alzheimer's disease (AD) by searching electronic bibliographic databases like Scopus, Proquest, ScienceDirect, PubMed, and Google. There was no imposed time limit. However, the search was limited to only English articles. The review protocol is registered on PROSPERO as CRD42022356301. A population, intervention, control, and outcomes (PICO) technique was utilized for report inclusion, and all reports were assessed for risk of bias by using the SYRCLE's RoB tool. The article's bibliographic information, induction model, type of proanthocyanidins, animal strain/weight/age, and outcome measurements were acquired from ten papers and are reported here. Further analysis was validated and determined for the review. The included studies met the review's inclusion criteria and suggested that proanthocyanidins have a neurocognitive effect against AD. Additionally, the effectiveness of proanthocyanidins in reducing oxidative stress, acetylcholinesterase activity, amyloid beta, its efficacy in alleviating superoxide dismutase, cognitive properties, and in facilitating cholinergic transmission in various models of AD has been collectively observed in ten studies.

medicine, research & experimental,biology
Protective effect of flavonoids on oxidative stress injury in Alzheimer's disease

Kaixuan Wang,Xinmei Chen

DOI: https://doi.org/10.1080/14786419.2024.2345760

2024-06-25

Natural Product Research

Abstract:Alzheimer's disease (AD) is the most common neurodegenerative disease, which is mainly caused by the damage of the structure and function of the central nervous system. At present, there are many adverse reactions in market-available drugs, which can't significantly inhibit the occurrence of AD. Therefore, the current focus of research is to find safe and effective therapeutic drugs to improve the clinical treatment of AD. Oxidative stress bridges different mechanism hypotheses of AD and plays a key role in AD. Numerous studies have shown that natural flavonoids have good antioxidant effects. They can directly or indirectly resist oxidative stress, inhibit Aβ aggregation and Tau protein hyperphosphorylation by activating Nrf2 and other oxidation-antioxidation-related signals, regulating synaptic function-related pathways, promoting mitochondrial autophagy, etc., and play a neuroprotective role in AD. In this review, we summarised the mechanism of flavonoids inhibiting oxidative stress injury in AD in recent years. Moreover, because of the shortcomings of poor biofilm permeability and low bioavailability of flavonoids, the advantages and recent research progress of nano-drug delivery systems such as liposomes and solid lipid nanoparticles were highlighted. We hope this review provides a useful way to explore safe and effective AD treatments.

chemistry, medicinal, applied
What does seropositivity for HTLV-I mean?

R. deShazo,P. Nolan

1989-12-01

Western Journal of Medicine

Abstract:WE LIVE IN A BIOLOGIC WORLD of predators and prey. It is nature's way. It is a matter ofinstinct and reality. Humans are not immune to preying upon others or themselves being prey. It is a competitive world. Success in this biologic world tends to come to those who can best take advantage of weakness. Civilization has progressed slowly and, we like to believe, inexorably. But the veneer of civilization is still very thin. The stronger tend to succeed and the weaker tend to succumb. This will probably never change and probably never should change, since it is rooted in the biologic nature of human society and the world as it is. Medicine, at least in the ancient Hippocratic tradition and probably long before that, called physicians to something ofa higher duty, that is, to care for the weak and afflicted, to try to postpone their death, and, if possible, to help restore their health and usefulness. It has been a profession where skills and knowledge are learned and used in the service of fellow humans who needed help. But physicians themselves have always been humans, and throughout all history, there have been some who preyed upon their patients and were suspected or known to take advantage of them, often for economic gain. So the fact that there are now predators in health care who prey upon the weak is really not new. The principal difference now is that the major predators are less apt to be personal physicians caring for their patients and much more likely to be third parties who, encouraged by society through government and business initiatives and armed with newly found fiscal strength because they pay most of the bills, are finding their prey in the relatively weakened position ofphysicians and patients in the business enterprise that health care has recently become. Physicians like to think ofmedicine as a noble profession. What does a noble profession do when it finds itselfand those it serves being preyed upon by stronger third parties who seem to hold most of the power? Its tradition is one of service, rather than one of individual or professional gain, yet it is being swept, almost as a matter of survival, into a new arena of predators and prey in health care. Neither the law, medicine, education, nor even some of the professionals of the cloth-all traditionally considered to be among the learned professions-have been immune to the temptation,
Naringenin Ameliorates Amyloid-Β Pathology and Neuroinflammation in Alzheimer’s Disease

Yueli Zhu,Xiaoming Guo,Shumin Li,Yue Wu,Feng Zhu,Chengfan Qin,Qin Zhang,Yunmei Yang

DOI: https://doi.org/10.1038/s42003-024-06615-6

IF: 6.548

2024-01-01

Communications Biology

Abstract:Alzheimer's disease (AD) is the most common cause of dementia characterized by amyloid-beta (A beta) deposition, tau hyperphosphorylation, and neuroinflammation. Naringenin (NRG), a natural flavonoid widely present in citrus fruits, has been reported can penetrate the blood-brain barrier and exert anti-inflammatory effects in the central nervous system. Here, we investigate the protective effects of long-term NRG treatment on AD. The novel object recognition test and Morris water maze test reveal that NRG treatment can improve the learning and memory ability of APP/PS1 mice. Besides, we find that NRG can significantly reduce A beta deposition, microglial and astrocytic activation, and pro-inflammatory cytokine levels in APP/PS1 mice. Results further show that NRG effectively decreases pro-inflammatory cytokines in LPS/A beta-stimulated BV2 cells. Lastly, the molecular mechanistic study reveals that NRG attenuates neuroinflammatory responses via inhibition of the MAPK signaling pathway in vivo and in vitro. Overall, NRG may emerge as a promising compound for the prevention and treatment of AD. A study reveals the protective effects of long-term naringenin treatment on Alzheimer's disease, including reducing A beta deposition, decreasing neuroinflammatory responses, and improving cognitive function
[Clinical considerations on pregnancy and childbirth in cardiopathicpatients. Review of 66 cases].

B. D'orso,E. Colizzi,A. Beretta,V. Marino

1969-06-01

Abstract:
Beneficial Fruit-Derived Phytochemicals in Treating Alzheimer’s Disease – A Review

Yurida Ni'ma Annisa,Vania Amanda Samor,Muthi Ikawati,Nunung Yuniarti

DOI: https://doi.org/10.24071/jpsc.004491

2023-12-23

Journal of Pharmaceutical Sciences and Community

Abstract:Fruits, as a major source of nutrition have been investigated for their emerging evidence of several neuroprotective activities beneficial to Alzheimer’s disease (AD). This paper discusses recent evidence suggesting several fruit-derived bioactive substances that possess anti-AD activity. The original articles from 2011–2022 were collected from Pubmed and Scopus with related keywords and filtered. Several fruit constituents have shown significant inhibitory action against β-amyloid and tau hyperphosphorylation, either directly or indirectly via secretase inhibition. Some were also found to be cholinesterase inhibitors with specific antioxidative roles, disruptors of the neuroinflammation system, and promoters of neurogenesis and the neurogenic process. Many fruit phytochemicals remarkably alter the capability defects shown in AD animal models, such as catechin, nobiletin, and alpha-mangostin. Therefore, further investigations exploring a certain bioactive isolate or formulated dosage form and its mechanism of action are necessary to provide effective prevention and supplementary treatment for AD.
Anti-dementia Activity of Nobiletin, a Citrus Flavonoid: A Review of Animal Studies

Akira Nakajima,Yasushi Ohizumi,Kiyofumi Yamada

DOI: https://doi.org/10.9758/cpn.2014.12.2.75

2014-08-28

Clinical Psychopharmacology and Neuroscience

Abstract:Alzheimer's disease (AD), the most common form of dementia among the elderly, is characterized by the progressive decline of cognitive function and has a detrimental impact worldwide. Despite intensive laboratory and clinical research over the last three decades, pharmacological options for the prevention and effective long-term treatment of AD are not currently available. Consequently, successful therapeutic and preventive treatments for AD are needed. When researching materials from natural resources having anti-dementia drug activity, we identified nobiletin, a polymethoxylated flavone from the peel of Citrus depressa. Nobiletin exhibited memory-improving effects in various animal models of dementia and exerted a wide range of beneficial effects against pathological features of AD including amyloid-β (Aβ) pathology, tau hyperphosphorylation, oxidative stress, cholinergic neurodegeneration and dysfunction of synaptic plasticity-related signaling, suggesting this natural compound could become a novel drug for the treatment and prevention of AD.

pharmacology & pharmacy,neurosciences
Molecular Level Insight into the Benefit of Myricetin and Dihydromyricetin Uptake in Patients with Alzheimer’s Diseases

Miaomiao Liu,Hong Guo,Zhongyuan Li,Chenghua Zhang,Xiaoping Zhang,Qinghua Cui,Jingzhen Tian

DOI: https://doi.org/10.3389/fnagi.2020.601603

IF: 4.8

2020-01-01

Frontiers in Aging Neuroscience

Abstract:Alzheimer’s disease (AD) is a neurodegenerative disease with a high incidence rate and complicated pathogenesis. Currently, all anti-AD drugs treat the symptoms of the disease, and with currently no cure for AD. Flavonoid containing natural products, Myricetin (MYR) and Dihydromyricetin (DMY), are abundant in fruits and vegetables, and have been approved as food supplements in some countries. Interestingly, MYR and DMY have been reported to have anti-AD effects. However, the underlying anti-AD mechanism of action of MYR and DMY is complex with many facets being identified. In this review, we explore the benefit of MYR and DMY in AD patients from a molecular level. Their mechanism of action are discussed from various aspects including amyloid β-protein (Aβ) imbalance, neuroinflammation, dyshomeostasis of metal ions, autophagy disorder, and oxidative stress.
Characterization of the productivity scholar researchers of CNPq in nursing: cross sectional study

R. Q. Souto,Gersiane da Silva Lacerda,G. M. C. Costa,A. Cavalcanti,Inácia Sátiro Xavier de França,Francisco Stélio de Sousa

DOI: https://doi.org/10.5935/1676-4285.20120025

2012-06-29

Abstract:This cross-sectional study aimed to investigate the profile of research productivity scholar from CNPq of the Nursing area. The sample consisted of 141 researchers and the research instrument consisted of a specific form including variables related to sociodemographic and curriculum characterization of the researchers. The data were organized in SPSS and were presented through descriptive statistics. We used the chi-square test and ANOVA. The significance level used in the statistical tests was 5%. It was found that the majority (97.16%) is female and is included in level 2 (61.70%), demonstrating the association between gender and the level of the researchers (p = 0.00). We conclude that there is a predominance of females, level 2, with the majority of researchers located in the Southeast, with doctoral training in Brazil and post-doctoral overseas
The Citrus Flavonoid Hesperetin Encounters Diabetes-Mediated Alzheimer-Type Neuropathologic Changes through Relieving Advanced Glycation End-Products Inducing Endoplasmic Reticulum Stress

Mei-Chou Lai,Wayne-Young Liu,Shorong-Shii Liou,I-Min Liu

DOI: https://doi.org/10.3390/nu14040745

IF: 5.9

2022-02-10

Nutrients

Abstract:The present study investigates whether hesperetin, a citrus flavonoid, can encounter advanced glycation end-product (AGE)-induced Alzheimer’s disease-like pathophysiological changes with the underlying mechanisms. SH-SY5Y cells pretreated with hesperetin before stimulation with AGEs (200 μg/mL) were assessed in the following experiments. Hesperetin (40 μmol/L) elevated the reduced cell viability induced by AGEs. Hesperetin ameliorated reactive oxygen species overproduction and the downregulation of superoxide dismutase, glutathione peroxidase, and catalase, triggered by AGEs. Amyloid precursor protein upregulation, accompanied by the increased production of Aβ, caused by AGEs, was reversed by hesperetin. However, hesperetin lowered β-site APP-cleaving enzyme 1 expression, inducing insulin-degrading and neprilysin expression. In addition, hesperetin downregulated the expressions of the AGEs-induced endoplasmic reticulum (ER) stress proteins, including 78-kDa glucose-regulated protein and C/EBP homologous protein, and lowered the phosphorylation of protein kinase R-like ER kinase and activating transcription factor 4. Hesperetin-pretreated cells had a minor apoptotic DNA fragmentation. Hesperetin is able to upregulate Bcl-2 protein expression, downregulate Bax expression, and decrease caspase-12/-9/-3 activity as well, indicating that it inhibits ER stress-mediated neuronal apoptosis. There is a similar effect between hesperetin and positive rosiglitazone control against Aβ aggravation of SH-SY5Y cell injury induced by AGEs. Thus, hesperetin might be a potential agent for treating glycation-induced Aβ neurotoxicity.

nutrition & dietetics
Neuroprotective Effects and Therapeutic Potential of the Citrus Flavonoid Hesperetin in Neurodegenerative Diseases

Jasmine A Evans,Patricia Mendonca,Karam F A Soliman,Jasmine A. Evans,Karam F. A. Soliman

DOI: https://doi.org/10.3390/nu14112228

IF: 5.9

2022-05-27

Nutrients

Abstract:Neurodegenerative disorders affect more than fifty million Americans each year and represent serious health threats as the population ages. Neuroinflammation and oxidative stress are critical in the onset, progression, and pathogenesis of neurodegenerative diseases such as Alzheimer's (AD), Parkinson's (PD), and amyotrophic lateral sclerosis (ALS). A wide range of natural compounds has been investigated because of their antioxidant, anti-inflammatory, and neuroprotective properties. The citrus flavonoid hesperetin (HPT), an aglycone of hesperidin found in oranges, mandarins, and lemons, has been extensively reported to exert neuroprotective effects in experimental models of neurogenerative diseases. This review has compiled multiple studies on HPT in both in vivo and in vitro models to study neurodegeneration. We focused on the modulatory effects of hesperetin on the release of cellular anti-inflammatory and antioxidative stress mediators. Additionally, this review discusses the hesperetin effect in maintaining the levels of microRNA (miRNA) and modulating autophagy as it relates to hesperetin's protective mechanisms against neurodegeneration. Moreover, this review is focused on providing experimental data for hesperetin's potential as a neuroprotective compound and discusses reported evidence that HPT crosses the blood–brain barrier. In summary, this review shows the evidence available in the literature to indicate the efficacy of hesperetin in delaying the onset of neurodegenerative diseases.

nutrition & dietetics
A Narrative Review of the Effects of Citrus Peels and Extracts on Human Brain Health and Metabolism

Kentaro Matsuzaki,Akira Nakajima,Yuanqiang Guo,Yasushi Ohizumi

DOI: https://doi.org/10.3390/nu14091847

IF: 5.9

2022-04-28

Nutrients

Abstract:As life expectancy increases, age-associated diseases such as Alzheimer's disease (AD) become a major health problem. The onset of AD involves neurological dysfunction due to amyloid-β accumulation, tau hyperphosphorylation, oxidative stress, and neuroinflammation in the brain. In addition, lifestyle-related diseases-such as dyslipidemia, diabetes, obesity, and vascular dysfunction-increase the risk of developing dementia. The world population ages, prompting the development of new strategies to maintain brain health and prevent the onset of dementia in older and preclinical patients. Citrus fruits are abundant polymethoxylated flavone and flavanone sources. Preclinical studies reported that these compounds have neuroprotective effects in models of dementia such as AD. Interestingly, clinical and epidemiological studies appear to support preclinical evidence and show improved cognitive function and reduced associated disease risk in healthy individuals and/or patients. This review summarizes the recent evidence of the beneficial effects of citrus peels and extracts on human cognition and related functions.
[Mechanism of action of benzothiadiazides in arterial hypertension: the energetic theory].

D. Mollé,E. Labeyrie,D. Daveloose,R. Salesse,J. Viret,F. Leterrier

Abstract:Hydrochlorothiazide, tienilic acid, chlorthalidone and indapamide inhibit membrane adenylate cyclase of pigeon erythrocytes in vitro. This effect is related to the action of these substances on the interface between the membranous phospholipids and adenylate cyclase. Indapamide with its strong lipophic properties, has a more specific action on the intracellular regulation of adenylate cyclase. The relationship between the inhibition of adenylate cyclase and the antihypertensive effects of these drugs is discussed.
Targeting NAD + Degradation: the Therapeutic Potential of Flavonoids for Alzheimer's Disease and Cognitive Frailty

Qingwei Ruan,Jian Ruan,Weibin Zhang,Feng Qian,Zhuowei Yu

DOI: https://doi.org/10.1016/j.phrs.2017.08.010

IF: 10.334

2018-01-01

Pharmacological Research

Abstract:Flavonoids are efficacious candidates as pharmaceuticals or nutraceuticals in the treatment of Alzheimer’s disease (AD), aging and other age-related chronic inflammatory diseases. Natural flavonoids reduce pathological hallmarks, extracellular amyloid deposits and neurofibrillary tangles by mediating amyloid precursor protein (APP) processing, Aβ accumulation and tau pathology. The antioxidant and anti-inflammatory actions as well as modulation of sirtuins and telomeres are also involved in the amelioration of aging, neurodegeneration and other age-related diseases. Recently, some flavonoids were shown to inhibit poly (ADP-ribose) polymerases (PARPs) and cyclic ADP-ribose (cADP) synthases (CD38 and CD157), elevate intracellular nicotinamide adenine dinucleotide+ (NAD+) levels and activate NAD+ dependent sirtuin −mediated signaling pathways. We summarized how flavonoids reduce the degradation of NAD+ with an emphasis on the mechanisms through which flavonoids affect the NAD+-sirtuin axis to protect against AD. Aging and age-related diseases as well as a decline in the physiological reserve are the risk factors for cognitive frailty. Flavonoids with multiple therapeutic targets may also be potential candidates for the prevention and treatment of cognitive frailty.
Research Progress on Alzheimer's Disease and Resveratrol

Yan Yan,Huihuang Yang,Yuxun Xie,Yuanlin Ding,Danli Kong,Haibing Yu

DOI: https://doi.org/10.1007/s11064-020-03007-0

IF: 4.4

2020-03-11

Neurochemical Research

Abstract:Alzheimer's disease (AD), a common irreversible neurodegenerative disease characterized by amyloid-β plaques, neurofibrillary tangles, and changes in tau phosphorylation, is accompanied by memory loss and symptoms of cognitive dysfunction. Increases in disease incidence due to the ageing of the population have placed a great burden on society. To date, the mechanism of AD and the identities of adequate drugs for AD prevention and treatment have eluded the medical community. It has been confirmed that phytochemicals have certain neuroprotective effects against AD. For example, some progress has been made in research on the use of resveratrol, a natural polyphenolic phytochemical, for the prevention and treatment of AD in recent years. Elucidation of the pathogenesis of AD will create a solid foundation for drug treatment. In addition, research on resveratrol, including its mechanism of action, the roles of signalling pathways and its therapeutic targets, will provide new ideas for AD treatment, which is of great significance. In this review, we discuss the possible relationships between AD and the following factors: synapses, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors (AMPARs), silent information regulator 1 (SIRT1), and estrogens. We also discuss the findings of previous studies regarding these relationships in the context of AD treatment and further summarize research progress related to resveratrol treatment.

biochemistry & molecular biology,neurosciences

1,2-dibromopyracylene: a new aromatic system.

Efficacy and molecular mechanisms of hesperidin in mitigating Alzheimer's disease: A systematic review

Iron stores in pregnancy.

Potential Benefits of Nobiletin, A Citrus Flavonoid, against Alzheimer’s Disease and Parkinson’s Disease

Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease

Therapeutic Effects of Plant Anthocyanin against Alzheimer's Disease and Modulate Gut Health, Short-Chain Fatty Acids

Neurocognitive effects of proanthocyanidin in Alzheimer's disease: a systematic review of preclinical evidence

Protective effect of flavonoids on oxidative stress injury in Alzheimer's disease

What does seropositivity for HTLV-I mean?

Naringenin Ameliorates Amyloid-Β Pathology and Neuroinflammation in Alzheimer’s Disease

[Clinical considerations on pregnancy and childbirth in cardiopathicpatients. Review of 66 cases].

Beneficial Fruit-Derived Phytochemicals in Treating Alzheimer’s Disease – A Review

Anti-dementia Activity of Nobiletin, a Citrus Flavonoid: A Review of Animal Studies

Molecular Level Insight into the Benefit of Myricetin and Dihydromyricetin Uptake in Patients with Alzheimer’s Diseases

Characterization of the productivity scholar researchers of CNPq in nursing: cross sectional study

The Citrus Flavonoid Hesperetin Encounters Diabetes-Mediated Alzheimer-Type Neuropathologic Changes through Relieving Advanced Glycation End-Products Inducing Endoplasmic Reticulum Stress

Neuroprotective Effects and Therapeutic Potential of the Citrus Flavonoid Hesperetin in Neurodegenerative Diseases

A Narrative Review of the Effects of Citrus Peels and Extracts on Human Brain Health and Metabolism

[Mechanism of action of benzothiadiazides in arterial hypertension: the energetic theory].

Targeting NAD + Degradation: the Therapeutic Potential of Flavonoids for Alzheimer's Disease and Cognitive Frailty

Research Progress on Alzheimer's Disease and Resveratrol